0001415889-24-003581.txt : 20240213 0001415889-24-003581.hdr.sgml : 20240213 20240213173025 ACCESSION NUMBER: 0001415889-24-003581 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simmons Jeffrey N CENTRAL INDEX KEY: 0001479079 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 24630265 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 form4-02132024_100208.xml X0508 4 2024-02-09 0001739104 Elanco Animal Health Inc ELAN 0001479079 Simmons Jeffrey N C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 true true false false PRESIDENT, CEO AND DIRECTOR 0 Deferred Stock Units 2024-02-09 4 A 0 173.4026 15.97 A Common Stock 173.4026 533.9157 D Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. /s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons 2024-02-13